Literature DB >> 21127178

Improving the therapeutic index in myeloma.

Paul G Richardson1.   

Abstract

Entities:  

Year:  2010        PMID： 21127178     DOI： 10.1182/blood-2010-10-306373

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors.

Authors:  Laura Tornatore; Annamaria Sandomenico; Domenico Raimondo; Caroline Low; Alberto Rocci; Cathy Tralau-Stewart; Daria Capece; Daniel D'Andrea; Marco Bua; Eileen Boyle; Mark van Duin; Pietro Zoppoli; Albert Jaxa-Chamiec; Anil K Thotakura; Julian Dyson; Brian A Walker; Antonio Leonardi; Angela Chambery; Christoph Driessen; Pieter Sonneveld; Gareth Morgan; Antonio Palumbo; Anna Tramontano; Amin Rahemtulla; Menotti Ruvo; Guido Franzoso
Journal:  Cancer Cell       Date:  2014-10-13       Impact factor: 31.743

Review 2.  Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.

Authors:  Federica Begalli; Jason Bennett; Daria Capece; Daniela Verzella; Daniel D'Andrea; Laura Tornatore; Guido Franzoso
Journal:  Biomedicines       Date:  2017-08-22

Review 3.  NF-κB in the crosshairs: Rethinking an old riddle.

Authors:  Jason Bennett; Daria Capece; Federica Begalli; Daniela Verzella; Daniel D'Andrea; Laura Tornatore; Guido Franzoso
Journal:  Int J Biochem Cell Biol       Date:  2017-12-23       Impact factor: 5.085
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.